Studies on glyphosate-induced carcinogenicity in mouse skin: a proteomic approach

Jasmine George1, Sahdeo Prasad, Zafar Mahmood

  • 1Proteomics Laboratory, Indian Institute of Toxicology Research (CSIR), Mahatma Gandhi Marg, Lucknow 226001 UP, India.

Journal of Proteomics
|January 5, 2010
PubMed

Insights

Glyphosate, a common herbicide, demonstrates tumor-promoting effects in mouse skin. Its mechanism involves altering protein expression similar to TPA, suggesting potential carcinogenic risks.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Proteomics

Background:

  • Glyphosate is a widely used herbicide with known toxic effects.
  • The carcinogenic potential of glyphosate in non-target species remains largely unknown.
  • Understanding glyphosate's impact on carcinogenesis is crucial for public health.

Purpose of the Study:

  • To investigate the carcinogenic effects of glyphosate using a mouse skin model.
  • To identify protein expression changes associated with glyphosate-induced skin carcinogenesis.
  • To explore the potential mechanism of glyphosate's action in skin cancer development.

Main Methods:

  • A two-stage mouse skin carcinogenesis model was employed.
  • Proteomic analysis, including 2D gel electrophoresis and mass spectrometry, was utilized.
  • Immunoblotting was used to validate differential protein expression.

Main Results:

  • Glyphosate exhibited tumor-promoting activity in the mouse skin model.
  • Proteomic analysis revealed differential expression of 22 protein spots.
  • Nine proteins, including translation elongation factor eEF-1 alpha and superoxide dismutase [Cu-Zn], showed similar expression patterns in glyphosate and TPA-treated groups.

Conclusions:

  • Glyphosate possesses tumor-promoting potential in skin carcinogenesis.
  • The mechanism of glyphosate-induced skin carcinogenesis may be similar to that of TPA.
  • Specific proteins like calcyclin and calgranulin-B could serve as biomarkers for glyphosate-induced skin cancer.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...